Somatic symptoms in treatment-resistant depression

George I. Papakostas, Timothy Petersen, John Denninger, Shamsah B. Sonawalla, Yasmin Mahal, Jonathan E. Alpert, Andrew A. Nierenberg, Maurizio Fava

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

The purpose of this work was to study the prevalence of somatic symptoms in patients with treatment-resistant depression (TRD) and their impact on the response to antidepressant treatment. Somatic symptoms were assessed during the screen visit with the Symptom Questionnaire (SQ) somatic symptom (SQ-SS) and somatic well-being sub-scales (SQ-SWB) in 40 patients with TRD enrolled in a 6-week open trial of nortriptyline. A logistic regression was used to test whether SQ-SS or SQ-SWB scores predicted clinical response to nortriptyline. Ninety-five percent of patients reported at least one somatic symptom. Higher SQ-SS scores during the screen visit predicted poorer response to nortriptyline. There was a trend for lower SQ-SWB scores to predict poor response to nortriptyline. None of the patients with SQ-SS scores above the mean for the sample responded to nortriptyline. The overwhelming majority of patients with TRD presented with somatic symptoms. In addition, a greater number of somatic symptoms during the screen visit placed patients at risk for further treatment resistance.

Original languageEnglish (US)
Pages (from-to)39-45
Number of pages7
JournalPsychiatry Research
Volume118
Issue number1
DOIs
StatePublished - May 1 2003
Externally publishedYes

Fingerprint

Treatment-Resistant Depressive Disorder
Nortriptyline
Medically Unexplained Symptoms
Surveys and Questionnaires
Antidepressive Agents
Cross-Sectional Studies
Logistic Models
Therapeutics

Keywords

  • Antidepressants
  • Nortriptyline
  • Response prediction
  • Symptom Questionnaire

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Papakostas, G. I., Petersen, T., Denninger, J., Sonawalla, S. B., Mahal, Y., Alpert, J. E., ... Fava, M. (2003). Somatic symptoms in treatment-resistant depression. Psychiatry Research, 118(1), 39-45. https://doi.org/10.1016/S0165-1781(03)00063-5

Somatic symptoms in treatment-resistant depression. / Papakostas, George I.; Petersen, Timothy; Denninger, John; Sonawalla, Shamsah B.; Mahal, Yasmin; Alpert, Jonathan E.; Nierenberg, Andrew A.; Fava, Maurizio.

In: Psychiatry Research, Vol. 118, No. 1, 01.05.2003, p. 39-45.

Research output: Contribution to journalArticle

Papakostas, GI, Petersen, T, Denninger, J, Sonawalla, SB, Mahal, Y, Alpert, JE, Nierenberg, AA & Fava, M 2003, 'Somatic symptoms in treatment-resistant depression', Psychiatry Research, vol. 118, no. 1, pp. 39-45. https://doi.org/10.1016/S0165-1781(03)00063-5
Papakostas GI, Petersen T, Denninger J, Sonawalla SB, Mahal Y, Alpert JE et al. Somatic symptoms in treatment-resistant depression. Psychiatry Research. 2003 May 1;118(1):39-45. https://doi.org/10.1016/S0165-1781(03)00063-5
Papakostas, George I. ; Petersen, Timothy ; Denninger, John ; Sonawalla, Shamsah B. ; Mahal, Yasmin ; Alpert, Jonathan E. ; Nierenberg, Andrew A. ; Fava, Maurizio. / Somatic symptoms in treatment-resistant depression. In: Psychiatry Research. 2003 ; Vol. 118, No. 1. pp. 39-45.
@article{a87b5a017ba14dddbd293f3ab3b1d384,
title = "Somatic symptoms in treatment-resistant depression",
abstract = "The purpose of this work was to study the prevalence of somatic symptoms in patients with treatment-resistant depression (TRD) and their impact on the response to antidepressant treatment. Somatic symptoms were assessed during the screen visit with the Symptom Questionnaire (SQ) somatic symptom (SQ-SS) and somatic well-being sub-scales (SQ-SWB) in 40 patients with TRD enrolled in a 6-week open trial of nortriptyline. A logistic regression was used to test whether SQ-SS or SQ-SWB scores predicted clinical response to nortriptyline. Ninety-five percent of patients reported at least one somatic symptom. Higher SQ-SS scores during the screen visit predicted poorer response to nortriptyline. There was a trend for lower SQ-SWB scores to predict poor response to nortriptyline. None of the patients with SQ-SS scores above the mean for the sample responded to nortriptyline. The overwhelming majority of patients with TRD presented with somatic symptoms. In addition, a greater number of somatic symptoms during the screen visit placed patients at risk for further treatment resistance.",
keywords = "Antidepressants, Nortriptyline, Response prediction, Symptom Questionnaire",
author = "Papakostas, {George I.} and Timothy Petersen and John Denninger and Sonawalla, {Shamsah B.} and Yasmin Mahal and Alpert, {Jonathan E.} and Nierenberg, {Andrew A.} and Maurizio Fava",
year = "2003",
month = "5",
day = "1",
doi = "10.1016/S0165-1781(03)00063-5",
language = "English (US)",
volume = "118",
pages = "39--45",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Somatic symptoms in treatment-resistant depression

AU - Papakostas, George I.

AU - Petersen, Timothy

AU - Denninger, John

AU - Sonawalla, Shamsah B.

AU - Mahal, Yasmin

AU - Alpert, Jonathan E.

AU - Nierenberg, Andrew A.

AU - Fava, Maurizio

PY - 2003/5/1

Y1 - 2003/5/1

N2 - The purpose of this work was to study the prevalence of somatic symptoms in patients with treatment-resistant depression (TRD) and their impact on the response to antidepressant treatment. Somatic symptoms were assessed during the screen visit with the Symptom Questionnaire (SQ) somatic symptom (SQ-SS) and somatic well-being sub-scales (SQ-SWB) in 40 patients with TRD enrolled in a 6-week open trial of nortriptyline. A logistic regression was used to test whether SQ-SS or SQ-SWB scores predicted clinical response to nortriptyline. Ninety-five percent of patients reported at least one somatic symptom. Higher SQ-SS scores during the screen visit predicted poorer response to nortriptyline. There was a trend for lower SQ-SWB scores to predict poor response to nortriptyline. None of the patients with SQ-SS scores above the mean for the sample responded to nortriptyline. The overwhelming majority of patients with TRD presented with somatic symptoms. In addition, a greater number of somatic symptoms during the screen visit placed patients at risk for further treatment resistance.

AB - The purpose of this work was to study the prevalence of somatic symptoms in patients with treatment-resistant depression (TRD) and their impact on the response to antidepressant treatment. Somatic symptoms were assessed during the screen visit with the Symptom Questionnaire (SQ) somatic symptom (SQ-SS) and somatic well-being sub-scales (SQ-SWB) in 40 patients with TRD enrolled in a 6-week open trial of nortriptyline. A logistic regression was used to test whether SQ-SS or SQ-SWB scores predicted clinical response to nortriptyline. Ninety-five percent of patients reported at least one somatic symptom. Higher SQ-SS scores during the screen visit predicted poorer response to nortriptyline. There was a trend for lower SQ-SWB scores to predict poor response to nortriptyline. None of the patients with SQ-SS scores above the mean for the sample responded to nortriptyline. The overwhelming majority of patients with TRD presented with somatic symptoms. In addition, a greater number of somatic symptoms during the screen visit placed patients at risk for further treatment resistance.

KW - Antidepressants

KW - Nortriptyline

KW - Response prediction

KW - Symptom Questionnaire

UR - http://www.scopus.com/inward/record.url?scp=0037621668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037621668&partnerID=8YFLogxK

U2 - 10.1016/S0165-1781(03)00063-5

DO - 10.1016/S0165-1781(03)00063-5

M3 - Article

VL - 118

SP - 39

EP - 45

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 1

ER -